Alpha Cognition Inc
ACOG5.800USD
+0.100+1.75%
Close 11/04, 16:00（ET）Quotes delayed by 15 min
92.93MMarket Cap
LossP/E TTM
More Details of Alpha Cognition Inc Company
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
Alpha Cognition Inc Info
Ticker SymbolACOG
Company nameAlpha Cognition Inc
IPO dateJun 09, 2021
CEOMr. Michael Mcfadden
Number of employees52
Security typeOrdinary Share
Fiscal year-endJun 09
Addressc/o 1200 - 750 West Pender Street
CityVANCOUVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeV6C 2T8
Phone16045649244
Websitehttps://www.alphacognition.com/
Ticker SymbolACOG
IPO dateJun 09, 2021
CEOMr. Michael Mcfadden
Company Executives of Alpha Cognition Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
324.01K
+44.95%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
14.14K
+22.61%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
324.01K
+44.95%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
14.14K
+22.61%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Oct 7
Updated: Tue, Oct 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Opaleye Management Inc.
8.97%
Solas Capital Management, LLC
6.10%
AWM Investment Company, Inc.
5.24%
Besser (James E)
4.80%
Ikarian Capital LLC
4.39%
Other
70.49%
Shareholders
Shareholders
Proportion
Opaleye Management Inc.
8.97%
Solas Capital Management, LLC
6.10%
AWM Investment Company, Inc.
5.24%
Besser (James E)
4.80%
Ikarian Capital LLC
4.39%
Other
70.49%
Shareholder Types
Shareholders
Proportion
Hedge Fund
23.76%
Investment Advisor/Hedge Fund
11.16%
Individual Investor
10.03%
Investment Advisor
1.44%
Bank and Trust
0.06%
Other
53.55%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
37
5.74M
27.45%
-1.60M
2025Q2
36
8.63M
53.86%
+808.67K
2025Q1
38
8.25M
51.64%
+1.18M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Solas Capital Management, LLC
1.28M
6.1%
-117.32K
-8.42%
Jun 30, 2025
AWM Investment Company, Inc.
1.10M
5.24%
--
--
Jun 30, 2025
Besser (James E)
1.00M
4.8%
+1.00M
--
Jan 15, 2025
Ikarian Capital LLC
917.87K
4.39%
-50.00K
-5.17%
Jun 30, 2025
Cable Car Capital LLC
869.00K
4.16%
+554.00
+0.06%
Jun 30, 2025
Sphera Funds Management Ltd.
376.65K
1.8%
-220.34K
-36.91%
Jun 30, 2025
Cawkell (Kenneth Anthony)
358.12K
1.71%
+139.64K
+63.92%
Apr 22, 2025
Mertz (Leonard Powell)
324.01K
1.55%
+100.48K
+44.95%
Apr 22, 2025
Havens (John P)
285.59K
1.37%
--
--
Apr 22, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
